Drugs / ELAD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01471028 | Feb 2013 → Jan 2015 | alcoholic hepatitis | Vital Therapies, Inc. | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ELAD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01471028 ↗ |
| Modality | Cell therapy | “Extracorporeal cellular therapy (ELAD)” PMID 29171941 ↗ Mar 2018 |